Lung cancer (non-small cell)
A Prospective Observational Study of cfDNA Monitoring in Metastatic Non-Small Cell Lung Cancer (NSCLC)
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
MOC Cancer Care and Research CentreMumbai, MaharashtraDirections ↗
Registry summary (technical)
A Prospective Observational Study of cfDNA-Guided Monitoring in Metastatic, Driver Mutation-Negative, Non-Small Cell Lung Cancer (NSCLC) - NSCLC_CfDNA
Sponsor: MOC Cancer Care and Research Centre
CTRI/2025/12/098710 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 12 Jan 2026 · read by us 5 Nov 2026